AGC (5201) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Net sales for Q1 FY2026 rose by ¥38.4 billion year-over-year to ¥538 billion, driven by yen depreciation, higher shipments in Essential Chemicals Southeast Asia, and pricing policies in architectural glass in Europe.
Operating profit increased by ¥12.6 billion to ¥38.5 billion, supported by sales growth, improved profitability in Life Science, and lower natural gas prices in Europe.
Profit before tax grew by ¥18 billion to ¥35 billion, aided by foreign exchange gains and cost reductions.
Profit attributable to owners of the parent increased by ¥16.2 billion to ¥22.8 billion year-over-year, with EPS rising to ¥107.73.
Comprehensive income for the period reached ¥35,005 million, reversing a loss in the prior year.
Financial highlights
Total assets reached ¥2,995,531 million as of March 31, 2026, up ¥45.5 billion from year-end, with equity attributable to owners at ¥1,494,870 million.
Operating cash flow was ¥42.6 billion; investment cash flow was negative ¥59.7 billion, resulting in free cash flow of negative ¥17.1 billion.
Cash and cash equivalents increased by ¥25.2 billion from December 2025 to March 2026, reaching ¥119,848 million.
CapEx for Q1 was ¥44.1 billion, down ¥5.5 billion quarter-on-quarter; depreciation was ¥48.1 billion, and R&D expenses were ¥13.9 billion.
Basic earnings per share rose to ¥107.73 from ¥31.35 year-over-year.
Outlook and guidance
Full-year FY2026 outlook unchanged: net sales ¥2,200 billion, operating profit ¥150 billion, profit before tax ¥124 billion, ROE 5.2%.
Profit attributable to owners projected at ¥77,000 million, with basic EPS forecast at ¥363.12.
Dividend forecast unchanged at ¥210 per share for FY2026.
Minimal expected impact from Middle East developments; measures in place for raw material supply stability.
Q2 is expected to see a dip in profit and net sales due to seasonality, especially in automotive and electronics.
Latest events from AGC
- Operating profit and ROE improved in FY2025; FY2026 targets further growth and stable dividends.5201
Q4 202513 Apr 2026 - Targets 8% ROE and 10% ROCE by 2026, focusing on growth, reforms, and sustainability.5201
IR Day 2024 Day 231 Jan 2026 - 8% ROE and 440bn yen EBITDA targeted for 2026 via transformation and disciplined investment.5201
IR Day 2024 Day 131 Jan 2026 - Operating and net profit improved despite lower sales, with stable outlook and dividends.5201
Q3 20255 Nov 2025 - Targets net zero carbon by 2050, driven by innovation, ESG, and talent development.5201
ESG Update26 Sep 2025 - FY2025 outlook cut as Chemicals, Life Science, and Electronics underperform; profit rebounds.5201
Q2 20251 Aug 2025 - Global leader in glass, chemicals, and life sciences, driving innovation and sustainable growth.5201
Corporate Presentation7 Jul 2025 - Ambidextrous strategy and sustainability drive growth, digitalization, and profitability targets.5201
Company Presentation7 Jul 2025 - Life Science impairments and Russian exit led to a sharp H1 2024 net loss despite sales growth.5201
Q2 202413 Jun 2025